The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 22.75%. However, over the past six months, we’ve seen a stronger performance of -7.34%. The price of ARCT fallen by 16.69% over the last 30 days. And in the last five days, it has surged by 25.63%.
The market performance of Arcturus Therapeutics Holdings Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $45.00 on 06/05/24, while the lowest value for the same duration was $14.30 on 12/19/24.
52-week price history of ARCT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Arcturus Therapeutics Holdings Inc’s current trading price is -53.71% away from its 52-week high, while its distance from the 52-week low is 45.66%. The stock’s price range during this period has varied between$14.30 and $45.00. The Arcturus Therapeutics Holdings Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.66 million for the day, a figure considerably higher than their average daily volume of 0.4 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Arcturus Therapeutics Holdings Inc (ARCT) has experienced a quarterly decline of -12.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 564.23M and boasts a workforce of 180 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 19.45, with a change in price of +1.62. Similarly, Arcturus Therapeutics Holdings Inc recorded 389,483 in trading volume during the last 100 days, posting a change of +8.43%.
ARCT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ARCT stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.
ARCT Stock Stochastic Average
As of today, Arcturus Therapeutics Holdings Inc’s raw stochastic average for the last 50 days stands at 89.33%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 93.82%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 73.62% and 58.54%, respectively.
